Lv4
418 积分 2025-08-14 加入
Myofibrillogenesis regulator 1 (MR-1): a potential therapeutic target for cancer and PNKD
3个月前
已完结
LuPARP: Phase 1 trial of 177Lu-PSMA-617 and olaparib in patients with metastatic castration resistant prostate cancer (mCRPC)
7个月前
已完结
Radiolabeling of CHX-A″-DTPA-Antibody Conjugates with [ 89 Zr]ZrCl 4
8个月前
已关闭
Combination Image-Guided and Antibody-Targeted α-Therapy Before Targeted Immunotherapy for Treatment of Solid Tumors
8个月前
已完结
Podophyllotoxin-induced acute kidney injury via the HMGB1/TLR4/MyD88/NF-κB axis in SD rats based on the toxicological evidence chain (TEC) concept via multiomic analysis
8个月前
已完结
Radiopharmaceuticals as combinatorial partners for immune checkpoint inhibitors
9个月前
已完结
Designed Ankyrin Repeat Protein–Mediated Peptide Nucleic Acid–Based Pretargeting: A Proof-of-Principle Study
9个月前
已完结
Translating the theranostic concept to neuro-oncology: disrupting barriers
9个月前
已完结
Pretargeted Mitochondrial Delivery of Organoarsenicals for Cancer Immunotherapy
10个月前
已完结
Biomaterial-mediated internal radioisotope therapy
10个月前
已完结
皖公网安备34019202002308
